Post-Market Surveillance (PMS) is the process of continuously monitoring the safety, quality, and performance of a medical device after it has been placed on the market. It helps manufacturers understand how their devices perform in real-world use and identify any issues that may require corrective action.
Regulatory authorities worldwide, including CDSCO (India), US FDA, EU MDR/IVDR, Health Canada, TGA Australia, and other international regulators, expect manufacturers to have systems in place to collect, review, and evaluate post-market information.
A PMS Plan describes how post-market information will be collected, monitored, and assessed. A PMS Report documents the findings from these activities, including trends, complaints, feedback, adverse events, and actions taken to maintain product safety and compliance.
A well-established PMS system helps manufacturers maintain regulatory compliance, improve product quality, support risk management activities, and demonstrate ongoing commitment to patient safety.
Support for establishing, maintaining, and improving post-market surveillance systems for medical devices and IVDs across regulated markets.
Practical implementation and regulatory compliance support for post-market surveillance systems, documentation, monitoring, and audit readiness.
Practical, risk-based support for building sustainable post-market surveillance systems for medical devices and IVDs across global markets.
FAQ
A PMS Plan describes how a manufacturer will collect, monitor, analyse and evaluate post-market information related to a medical device or IVD.
PMS helps manufacturers monitor product performance, identify emerging risks, improve product quality and maintain regulatory compliance.
Customer complaints, adverse events, service records, returned products, literature reviews, market feedback, and trend data are commonly reviewed.
Most regulatory authorities expect manufacturers to perform post-market monitoring activities, although documentation requirements may vary by country and device classification.
A PMS Report generally summarizes post-market data collected, analysis performed, identified trends, conclusions and any corrective actions taken.
PMS should be an ongoing process throughout the product lifecycle. Reporting frequency depends on regulatory requirements and device risk classification.
PMS data helps verify whether existing risk controls remain effective and whether any new risks have emerged during actual product use.
Yes. Customer complaints are one of the most important sources of post-market information and trend analysis.
Yes. We can review existing PMS Plans, PMS Reports and related procedures to identify compliance gaps and improvement opportunities.
Yes. We provide PMS documentation and compliance support for both Medical Devices and In Vitro Diagnostic Devices (IVDs).
Fill in the form and our team will get back to you shortly.
Reach our regulatory experts directly.